|
| |
| | | 66380 | | 05.09.2017 | | Merck (Schweiz) AG | | | | | | | | | | | | | 07.16.10. | | | | 07.16.10. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Bavencio 200 mg/10 ml | Konzentrat zur Herstellung einer Infusionslösung | Concentrate for infusion (Avelumabum 200mg / 10ml) | Codice | |
|
|
|
